Skip to content

Clinical Study on the Effects of Had Einstein Neuroacid Student Formula Milk Powder on Improving Children's Cognitive Function

Clinical Study on the Effects of Had Einstein Neuroacid Student Formula Milk Powder on Improving Children's Cognitive Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119411
Enrollment
Unknown
Registered
2026-02-26
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children's cognitive function

Interventions

Trial group:Twice daily, morning and evening, dissolve 25g (one packet) of powdered milk in 150ml of lukewarm water (around 50°C). Stir thoroughly before consumption.

Sponsors

Guangdong Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Age 6-16 years, no gender restriction; 2. Good health, with specific requirements: no history of neurological, psychiatric, or major systemic diseases; normal physical examination, blood routine, liver and kidney function prior to enrollment; vital signs such as body temperature and blood pressure maintained within normal ranges; no metabolic diseases; 3. Able to comply with written and oral instructions from research staff and adhere to all tests and requirements; 4. Willing to voluntarily participate in this study, with the subject or their legal guardian able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Individuals currently taking or who have taken any cognitive-enhancing supplements or medications within the past 3 months; 2. Individuals currently participating in or who have participated in any memory enhancement classes or tutoring programs within the past 3 months; 3. Individuals with organic disorders such as cerebral palsy, schizophrenia, visual/auditory/motor impairments, emotional disorders, social maladjustment, or physical illnesses; 4. Individuals with lactose intolerance, milk protein allergy, or allergies to other ingredients; 5. Participants deemed unsuitable for this study by the investigator.

Design outcomes

Primary

MeasureTime frame
Change from baseline in Raven's Standard Progressive Matrices (SPM) score;Change from baseline in Digit Span Test score;

Secondary

MeasureTime frame
Subject Satisfaction Assessment;

Countries

China

Contacts

Public ContactLü Qin

Guangdong Hospital of Integrated Traditional Chinese and Western Medicine

erkelq@sina.com+86 139 2771 8597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026